Remedy Science closes Series A funding round led by L Catterton

Dermatologist-founded skincare brand Remedy Science on Thursday revealed the closing of Series A funding round led by investment firm heavyweight, L Catterton.

The fundraise, whose financial terms were not disclosed, also included participation from existing investor Norwest and new investor Sonoma Brands Capital.

Founded by board-certified dermatologist Dr. Muneeb Shah in 2024, Remedy was launched “to mirror the way dermatologists approach skin in clinic,” addressing the concerns they see every day, including dark spots, dryness, fine lines, dullness, keratosis pilaris, and sensitive skin, according to a press release.

“For years, I saw patients who were doing everything right but still struggling to find products that delivered meaningful results without irritation or unnecessary complexity. Remedy was created to modernize dermatologist-developed skincare,” said Dr. Shah.

“Each formula starts with a real patient need. We then innovate with the latest ingredient technologies to create clinically tested, high-efficacy formulas with a focus on visible results and safety for sensitive skin.”

In the last two years, the Los Angeles-based skincare brand has logged growth across all online channels, including its direct-to-consumer (DTC) website, Amazon, and TikTok Shop. Last December, the business also launched across Target stores nationwide.

The latest Series A investment will support Remedy’s next phase of growth, including advancing clinical research, expanding its pipeline of dermatologist-developed products, building a best-in-class team and improving inventory depth to meet increasing demand across DTC, Amazon, and Target, the company said.

The company added it also plans to deepen its capabilities across formulation, testing, and consumer education as it continues building a scaled dermocosmetic platform.

“We seek to partner with exceptional founders building brands that will redefine categories, and we believe Remedy is uniquely modernizing dermatological skincare,” said Tehmina Haider, partner at L Catterton.

“As both a clinician and a consumer educator, Dr. Shah has built a portfolio of simple, effective, and accessibly priced products that leverage advanced ingredient technologies to address real patient needs — and that is what will define the next generation of dermocosmetics. The brand’s rapid growth reflects deep consumer demand for affordable, clinically-grounded skincare, and we are thrilled to partner with the Remedy team on their next chapter.”